Investigational Site Number 250001
Saint-Herblain 44805
0 studies enrolling now · 2 studies all time
What they study most
Non-small Cell Lung Cancer, Squamous Cell Lung Cancer
Studies at this site
- Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) — Completed
- Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer — Completed